PTC Therapeutics, Inc. (PTCT)
84.85
-4.70
(-5.25%)
USD |
NASDAQ |
Jul 10, 16:00
84.88
+0.03
(+0.04%)
After-Hours: 20:00
PTC Therapeutics Price : 84.85 for July 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 10, 2026 | 89.71 | 89.71 | 83.83 | 84.85 | 1.067M |
| Jul 09, 2026 | 89.01 | 90.87 | 85.40 | 89.55 | 1.270M |
| Jul 08, 2026 | 87.90 | 89.85 | 85.60 | 88.57 | 1.328M |
| Jul 07, 2026 | 86.84 | 89.80 | 84.76 | 89.20 | 1.411M |
| Jul 06, 2026 | 84.14 | 87.07 | 82.70 | 85.44 | 3.807M |
| Jul 02, 2026 | 81.27 | 83.37 | 80.76 | 83.31 | 6.778M |
| Jul 01, 2026 | 82.50 | 82.78 | 81.00 | 81.35 | 1.222M |
| Jun 30, 2026 | 81.97 | 83.22 | 80.68 | 81.57 | 2.376M |
| Jun 29, 2026 | 83.55 | 84.37 | 80.21 | 81.57 | 4.295M |
| Jun 26, 2026 | 84.69 | 85.83 | 83.25 | 84.43 | 3.903M |
| Jun 25, 2026 | 85.10 | 87.03 | 83.94 | 84.51 | 1.987M |
| Jun 24, 2026 | 82.99 | 85.15 | 81.81 | 84.41 | 3.321M |
| Jun 23, 2026 | 81.05 | 83.05 | 80.30 | 82.13 | 2.307M |
| Jun 22, 2026 | 80.00 | 81.71 | 79.50 | 80.96 | 2.414M |
| Jun 18, 2026 | 79.58 | 80.00 | 78.10 | 78.98 | 2.870M |
| Jun 17, 2026 | 75.56 | 79.60 | 74.86 | 78.53 | 3.184M |
| Jun 16, 2026 | 75.40 | 76.95 | 72.04 | 73.27 | 6.044M |
| Jun 15, 2026 | 72.02 | 77.13 | 71.80 | 76.77 | 3.591M |
| Jun 12, 2026 | 74.71 | 75.93 | 74.36 | 75.14 | 1.075M |
| Jun 11, 2026 | 73.40 | 75.51 | 72.66 | 74.71 | 2.245M |
| Jun 10, 2026 | 72.72 | 75.09 | 72.72 | 73.35 | 1.211M |
| Jun 09, 2026 | 73.14 | 74.29 | 71.30 | 73.68 | 1.874M |
| Jun 08, 2026 | 70.96 | 71.91 | 69.74 | 70.87 | 1.293M |
| Jun 05, 2026 | 70.78 | 72.97 | 69.92 | 70.97 | 937082.0 |
| Jun 04, 2026 | 69.54 | 71.73 | 69.46 | 70.64 | 1.098M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Keros Therapeutics, Inc. | 11.80 |
| Insmed, Inc. | 115.61 |
| Madrigal Pharmaceuticals, Inc. | 536.70 |
| Protagonist Therapeutics, Inc. | 131.42 |
| Nuvalent, Inc. | 123.90 |
Price Related Metrics
| PS Ratio | 8.424 |
| Earnings Yield | -2.76% |
| Market Cap | 7.033B |